MiNK Therapeutics Inc.
(INKT)
undefined
undefined%
At close: undefined
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | 2.70B | - | - | 689.63K |
Cost of Revenue | 204.62K | 30.95B | 28.36B | 55.06K | - |
Gross Profit | -204.62K | -28.24B | -28.36B | -55.06K | 689.63K |
Operating Income | -22.92M | -30.95M | -28.36M | -14.64M | -22.28M |
Interest Income | 463.26K | 253.32K | 2.43K | 2.44K | 1.56K |
Pretax Income | -22.46M | -27.99M | -30.21M | -16.24M | -23.80M |
Net Income | -22.46M | -24.78M | -23.11M | -15.68M | -25.91M |
Selling & General & Admin | 7.43M | 7.83M | 4.64M | 1.29M | 3.83M |
Research & Development | 15.49M | 23.12M | 13.97M | 9.51M | 19.65M |
Other Expenses | - | 2.70M | -9.53M | -3.00M | 551.24K |
Operating Expenses | 22.92M | 30.95M | 18.61M | 10.80M | 23.48M |
Interest Expense | - | 253.32K | 2.43M | 2.44M | 1.56M |
Selling & Marketing Expenses | - | - | - | - | - |
Cost & Expenses | 22.92M | 30.95M | 18.61M | 10.80M | 23.48M |
Income Tax | - | -3.21M | -7.10M | -560.38K | 2.11M |
Shares Outstanding (Basic) | 34.36M | 33.67M | 33.48M | 33.09M | 33.09M |
Shares Outstanding (Diluted) | 34.36M | 33.67M | 33.48M | 33.09M | 33.09M |
EPS (Basic) | -0.65 | -0.74 | -0.69 | -0.47 | -0.78 |
EPS (Diluted) | -0.65 | -0.74 | -0.69 | -0.47 | -0.78 |
EBITDA | -22.25M | -30.83M | -27.70M | -13.74M | -22.20M |
Depreciation & Amortization | 204.62K | 121.75K | 77.96K | 55.06K | 36.82K |